A clinical study on glaucoma and genetic analysis of glaucoma

A clinical Study And genetic analysis of Glaucoma Individuals classified by Doshaja prakruti - An open labelled double arm randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025019

Enrollment

100

Registered

2020-05-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

Intervention1: Swarnagairikadi gutikanjana: Local application 60mg BD for 3 months Control Intervention1: Swarnagairikadi gutikanjana and Rasayanadi yoga: Rasayanadi yoga orally with lukewarm water BD

Eligibility

Inclusion criteria

Inclusion criteria: POAG patients having IOP Visual acuity >6/60 and clear media

Exclusion criteria

Exclusion criteria: All types of PACG & cataract SEcondary and developmental Glaucoma including exfoliative Glaucoma, pigmentary Glaucoma , trauma induced, inflammatory Glaucoma End stage (advanced) GON or OA Visual acuity <6/60

Design outcomes

Primary

Measure	Time frame
1. Establish relationship between doshaj prakruti and genetic expression of Glaucoma 2. change in Clinical features of kaphaj Adhimantha - Primary open angle glaucomaTimepoint: 2 years	—

Secondary

Measure	Time frame
Overall improvement in Quality of Life related to Ocular HealthTimepoint: 120 days	—

Countries

India

Contacts

Public ContactDr Narayana Bavalatti

CSIR

bhavana.p@igib.res.in1129879323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026